These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38408556)

  • 1. Silencing of METTL3 inhibits m6A methylation of NEK7 to suppress pyrolysis in an HT-22 cell-based model of intracerebral hemorrhage.
    Hong L; Zhuo T; Jing S
    Brain Res; 2024 May; 1831():148828. PubMed ID: 38408556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 silenced inhibited the ferroptosis development via regulating the TFRC levels in the Intracerebral hemorrhage progression.
    Zhang L; Wang X; Che W; Zhou S; Feng Y
    Brain Res; 2023 Jul; 1811():148373. PubMed ID: 37105375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner.
    Tang Z; Huang X; Mei H; Zheng Z
    J Bioenerg Biomembr; 2024 Apr; 56(2):149-157. PubMed ID: 38319402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
    Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
    Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 Regulates the m
    Xiong X; Xiong H; Peng J; Liu Y; Zong Y
    Cartilage; 2023 Sep; ():19476035231200336. PubMed ID: 37724835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A.
    Wang X; Hu M; Yu L; Wang X; Jiang X; Zhang G; Ding K
    Hematol Oncol; 2022 Oct; 40(4):567-576. PubMed ID: 35446451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A reader YTHDC2 mediates NCOA4 mRNA stability affecting ferritinophagy to alleviate secondary injury after intracerebral haemorrhage.
    Li F; Wang F; Wang L; Wang J; Wei S; Meng J; Li Y; Feng L; Jiang P
    Epigenetics; 2024 Dec; 19(1):2326868. PubMed ID: 38465865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Egr1 promotes Nlrc4-dependent neuronal pyroptosis through phlda1 in an in-vitro model of intracerebral hemorrhage.
    Wang J; Gu D; Jin K; Shen H; Qian Y
    Neuroreport; 2024 Jun; 35(9):590-600. PubMed ID: 38652514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7.
    Zhou X; Yang X; Huang S; Lin G; Lei K; Wang Q; Lin W; Li H; Qi X; Seriwatanachai D; Yang S; Shao B; Yuan Q
    Adv Sci (Weinh); 2024 Jul; 11(26):e2308786. PubMed ID: 38696610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated N6-methyladenosine┬ámethylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
    Ma XX; Cao ZG; Zhao SL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer.
    Yu HY; Yang L; Liu YC; Yu AJ
    PeerJ; 2023; 11():e16308. PubMed ID: 38025760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression.
    Zhang L; Wang X; Che W; Yi Y; Zhou S; Feng Y
    Bioengineered; 2022 Jun; 13(6):14215-14226. PubMed ID: 35758287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.